Reintervention after percutaneous mitral balloon commissurotomy in patients with rheumatic heart disease: feasibility of surgical mitral valve repair.

ABSTRACT:

Background

Currently, mitral valve replacement is the primary method of reintervention for patients with rheumatic heart disease (RHD) after percutaneous mitral balloon commissurotomy (PMBC). This study aims to investigate the feasibility of mitral valve repair in such patients and report its therapeutic outcomes compared to mitral valve replacement.

Methods

Data from patients with previous PMBC who underwent mitral valve surgery as disease progression between January 2011 and August 2023 were retrospectively analyzed. The patients were divided into two groups: the repair group and the replacement group. The stabilized inverse probability of treatment weighting (SIPTW) method was used to balance baseline characteristic differences between the two groups. Clinical outcomes in

SUBMITTER: Li X 

PROVIDER: S-EPMC11898404 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature